ABSTRACT
Miíase é a presença de larvas de moscas em tecidos do homem ou de outros animais vertebrados, onde se nutrem e evoluem como parasitos. Erisipela é uma celulite superficial que apresenta comprometimento do plexo linfático subjacente, cujo principal agente etiológico é Streptococcus (Rosenbach,1884) beta hemolítico do grupo A de Lancefield. Caracteriza-se por placas eritematosas acompanhadas de dor e edema. Este é o relato de um caso raro de paciente idosa internada em hospital público para tratamento de erisipela bolhosa no membro inferior esquerdo, em cujas lesões, durante a internação, foi detectada a presença de miíase. Foram retiradas várias larvas vivas com auxílio de pinça e prescrita ivermectina para erradicar possíveis larvas remanescentes. O diagnóstico precoce e o tratamento correto das lesões primárias são fundamentais para evitar a ocorrência de afecções como a miíase, cuja instalação atrasa o tratamento e pode agravar o prognóstico.
Myiasis is the presence of fly larvae in tissues of humans or other vertebrates,where they feed and develop as parasites. Erysipelas is a superficial cellulitis with involvement of underlying lymphatic plexus, characterized by erythematous plaques accompanied by pain and swelling. We report a case of an aged patient admitted to a public hospital for treatment of bullous erysipelas in the left lower limb, who developed cutaneous myiasis during hospitalization. Several larvae wereremoved with the aid of forceps and ivermectin was prescribed to eradicate possible remaining larvae. Early diagnosis and correct treatment of the lesions are essential to prevent the occurrence of diseases such as myiasis.
Subject(s)
Humans , Female , Aged , Skin Diseases , Skin Diseases, Vesiculobullous/therapy , Diptera , Erysipelas/drug therapy , MyiasisABSTRACT
La prise en charge d`un erysipele de jambe est a adapter en fonction de la severite de l`atteinte cutanee; du retentissement de l`infection sur l`etat general; et des antecedents du patient. L`antibiotherapie reduit la mortalite; les complications; la duree de l`infection et les douleurs de l`erysipele
Subject(s)
Acetaminophen/administration & dosage , Acetaminophen/adverse effects , Anti-Bacterial Agents , Anti-Bacterial Agents/therapeutic use , Drug Interactions , Erysipelas/drug therapyABSTRACT
Erisipela y celulitis son causa frecuente de morbilidad y hospitalización; sin embargo, no existen estudios nacionales que caractericen a este grupo de pacientes. El objetivo del trabajo fue describir aspectos epidemiológicos y clínicos de pacientes hospitalizados por erisipela o celulitis en el Servicio de Dermatología del Hospital Clínico de la Universidad de Chile, en el período de mayo del año 2006 hasta abril del 2007. Se hospitalizó un total de 32 pacientes, 31 con diagnóstico de celulitis y uno de erisipela. Al ingreso 36 por ciento presentó fiebre. La localización más frecuente fue en extremidades inferiores. En relación a factores de riesgo, 72 por ciento presentó tiña pedis, 53 por ciento, tabaquismo y 34 por ciento, obesidad. El 65 por ciento recibió tratamiento antibiótico con cefazolina endovenosa. El promedio de estadía hospitalaria fue 5,3 días. Los resultados encontrados son concordantes con estudios internacionales. Los pacientes tuvieron una evolución satisfactoria; sin embargo, es importante no olvidar que a estas piodermias pueden asociarse graves complicaciones locales y sistémicas si no son diagnosticadas y tratadas oportunamente.
Erysipelas and cellulitis are common causes of morbidity and hospitalization. However there are no national studies that describe this group of patients.The aim of this study was to describe epidemiological and clinical features of patients admitted in our service with diagnosis of erysipelas and cellulitis in the period between May 2006 and April 2007. From a total of 32 patients, 31 presented cellulitis and 1 erysipelas. At the moment of admission 36 percent of the patients presented fever. The most frequent localization was the lower limbs. Within risk factors, 72 percent presented tinea pedis, 53 percent were smokers and 34 percent obese. Within treatment, 65 percent received endovenous cefazolin. Average hospitalization period was 5.3 days.In conclusion, this study showed no significant differences from those internationally published. Patients had a satisfactory evolution. It is, however, important not to forget the serious local and systemic complications that this infections may lead to if they are overlooked.
Subject(s)
Humans , Male , Female , Middle Aged , Cellulite/epidemiology , Erysipelas/epidemiology , Hospitalization , Anti-Bacterial Agents/therapeutic use , Cefazolin/therapeutic use , Cellulite/complications , Cellulite/drug therapy , Chile/epidemiology , Erysipelas/complications , Erysipelas/drug therapy , Prospective Studies , Risk FactorsABSTRACT
Erysipelas is an acute bacterial infection of the dermis and hypodermis generally caused by streptococcus. This affection is rare at the upper limb. The authors report the observation of three patients of the 4[th] and the 7[th] decade presenting an erysipelas at the upper limb having evolved favorably under antibiotic treatment and hospitalisation in two cases. The erysipelas is of clinical diagnosis basing on general and local signs. The portal of entry must be always looked for and treated. It represents with the diabetes, the obesity and the lymphedema a factor of gravity of this pathology
Subject(s)
Humans , Female , Upper Extremity , Erysipelas/drug therapy , Fasciitis, Necrotizing/surgeryABSTRACT
We conducted a retrospective at the department of dermatology of charles. Nicolle hospital of Tunis between January 1994 and December 2000 to determine the epidemiological, clinical profile and the evolution of erysipelas. A total of 647 patients were studied. The mean age was 44.73 years and sex ratio about 1.55. erysipelas predominately involved in the lower limbs [91.2%]. Antecedents of erysipelas were found in 26.12%. Portal of entry was found in 76.66% represented essentially by toe-web intertrigo. 26.6% of patients were hospitalized. Erysipelas can be controlled with antibiotics; treatment is essentially based on penicillin G 4 mega units intramuscularly every day [60.58%] for mean duration of 10.13 days. Satisfying results were observed in 87.78%. Erysipelas is common disease source of over morbidity. Many predisposing factors were incriminated, account for the frequency of recurrence, justifying implement of primary and secondary prevention
Subject(s)
Humans , Male , Female , Erysipelas/drug therapy , Retrospective StudiesABSTRACT
Se revisan 20 casos de infecciones de tejidos blandos hospitalizados en el Servicio de Cirugía del Hospital San Juan de Dios (1990-1998). De estos, 10 correspondieron a fasceítis, 9 a celulitis y 1 caso de erisipela. La etiología fue predominantemente polimicrobiana en la fasceítis necrotizante (80 por ciento) y monomicrobiana en la celulitis (55 por ciento). La evolución clínica fue favorable en el 100 por ciento de los casos de erisipela y celulitis, los cuales requirieron solamente tratamiento antimicrobiano. Falleció el 20 por ciento de los pacientes con fasceítis necrotizante y otro debió ser sometido a amputación. El tratamiento de estos casos es fundamentalmente quirúrgico, asociado a terapia antimicrobiana
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Cellulitis/etiology , Erysipelas/etiology , Fasciitis, Necrotizing/etiology , Soft Tissue Infections/classification , Anti-Bacterial Agents/therapeutic use , Cellulitis/drug therapy , Cellulitis/microbiology , Clinical Evolution , Erysipelas/drug therapy , Erysipelas/microbiology , Fasciitis, Necrotizing/drug therapy , Fasciitis, Necrotizing/microbiology , Fasciitis, Necrotizing/surgery , Risk Factors , Soft Tissue Infections/drug therapy , Soft Tissue Infections/etiology , Soft Tissue Infections/surgeryABSTRACT
La erisipela es una infección de los linfáticos de la piel de frecuente diagnóstico en nuestro medio. Se evaluaron 100 historias de pacientes ingresados al Hospital Universitario de Caracas con diagnóstico de erisipela. El 90% de los casos se localizó en miembros inferiores, siendo micosis superficiales y varices los factores predisponentes más frecuentes. Se describen las características clínicas de los pacientes, así como su evolución con los diferentes tratamientos. Se plantea la pobre sensibilidad de los estudios bacteriológicos y la importancia en el diagnóstico clínico preciso
Subject(s)
Child , Adolescent , Adult , Middle Aged , Humans , Male , Female , Erysipelas/diagnosis , Erysipelas/drug therapy , Penicillins/therapeutic useABSTRACT
Os autores realizaram um ensaio clínico com 10 pacientes acometidos de erisipela que foram submetidos a tratamento com netilmicina na dose de 150 mg de 12/12 horas, durante 10 dias. A análise dos resultados demonstrou um índice máximo de 100% de cura sem a constataçäo de efeitos colaterais ototóxicos ou nefrotóxicos perceptíveis. Esses resultados evidenciaram o excelente desempenho do referido antibiótico frente a esse tipo de infecçäo, o que o qualifica como excelente alternativa terapêutica